Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline. | Thorax | 2023 | 37657926 | PubTator, text mining | PubMed |
| Editorial: Case reports in respiratory pharmacology 2022. | Front Pharmacol | 2023 | 37654611 | PubTator, text mining | PubMed |
| The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma. | Biomed Pharmacother | 2023 | 37651801 | PubTator, text mining | PubMed |
| Shared genetic architecture of blood eosinophil counts and asthma in UK Biobank. | ERJ Open Res | 2023 | 37650091 | PubTator, text mining | PubMed |
| Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics. | Allergy | 2023 | 37643083 | PubTator, text mining | PubMed |
| A Case of Allergic Bronchopulmonary Aspergillosis With Failure of Benralizumab and Response to Dupilumab. | Cureus | 2023 | 37637670 | PubTator, text mining | PubMed |
| High Transcriptional Activity and Clinical Correlations in Eosinophils of Patients with Late-Onset Asthma. | J Asthma Allergy | 2023 | 37637476 | PubTator, text mining | PubMed |
| Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study. | J Clin Med | 2023 | 37629217 | PubTator, text mining | PubMed |
| Perspectives of Proteomics in Respiratory Allergic Diseases. | Int J Mol Sci | 2023 | 37629105 | PubTator, text mining | PubMed |
| Precision medicine advances in idiopathic pulmonary fibrosis. | EBioMedicine | 2023 | 37625268 | PubTator, text mining | PubMed |
| Dupilumab in a patient with severe asthma and glucocorticoid hypersensitivity: a case report. | J Int Med Res | 2023 | 37607026 | PubTator, text mining | PubMed |
| Pulmonary Vascular Differences in Eosinophilic Asthma after 2.5 Years of Anti-IL-5Rα Treatment. | Am J Respir Crit Care Med | 2023 | 37603773 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation association study of circulating IgE levels identifies novel targets for asthma. | EBioMedicine | 2023 | 37598461 | PubTator, text mining | PubMed |
| Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells. | Cell Rep Med | 2023 | 37586321 | PubTator, text mining | PubMed |
| Correction: New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. | Clin Sci (Lond) | 2023 | 37584241 | PubTator, text mining | PubMed |
| Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review. | Front Med (Lausanne) | 2023 | 37575981 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target? | Int J Mol Sci | 2023 | 37569787 | PubTator, text mining | PubMed |
| Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection. | Respir Med Case Rep | 2023 | 37560613 | PubTator, text mining | PubMed |
| An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma. | Clin Exp Med | 2023 | 37555911 | PubTator, text mining | PubMed |
| Eosinophilic gastroenteritis - a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment. | Prz Gastroenterol | 2023 | 37538288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=16